Malaria vaccine - CEL-SCI
Latest Information Update: 24 Sep 2021
At a glance
- Originator CEL-SCI Corporation; Naval Medical Research Center
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malaria